BOSTON, Jan. 5, 2015 /PRNewswire/ -- PAREXEL
International Corporation (NASDAQ: PRXL) announced today that it
will be presenting at the JP Morgan Healthcare Conference on
Wednesday, January 14, 2015, in San
Francisco. Josef von
Rickenbach, Chairman and Chief Executive Officer, will be
making a presentation on PAREXEL and discussing business
developments at 11:00 a.m. PT.
A live webcast of the presentation will be available through the
"Investors" section of PAREXEL's website at www.PAREXEL.com
in the Upcoming Events portion of the main page, and a replay of
the presentation will be available on the website for 90 days after
the presentation.
About PAREXEL International
PAREXEL International Corporation is a leading global
biopharmaceutical services organization, providing a broad range of
knowledge-based contract research, consulting, medical
communications, and technology solutions and services to the
worldwide pharmaceutical, biotechnology and medical device
industries. Committed to providing solutions that expedite
time-to-market and peak-market penetration, PAREXEL has developed
significant expertise across the development and commercialization
continuum, from drug development and regulatory consulting to
clinical pharmacology, clinical trials management, medical
education and reimbursement. PAREXEL Informatics provides advanced
technology solutions, including medical imaging, to facilitate the
clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 81
locations in 51 countries around the world, and has approximately
15,980 employees. For more information about PAREXEL
International visit www.PAREXEL.com.
Contact:
Jill Baker, Corporate Vice
President, Investor Relations
PAREXEL International
Tel: +781-434-4118
Email: Jill.Baker@parexel.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/parexel-international-to-present-at-jp-morgan-healthcare-conference-300015551.html
SOURCE PAREXEL International Corporation